Active	Status	Sponsor type	Region	Phase	Filter
6 Active 0 Inactive 6 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes: « April » « 2025 » M T W T F S S 31 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 1 2 3 4   - « April » « 2025 » M T W T F S S 31 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 1 2 3 4   Show only changed items Enrollment:

Advanced Filters

6 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
bexicaserin (LP352) / Lundbeck
NCT06660394: A Phase 3, Placebo-Controlled Study to Investigate LP352 in Children and Adults with Dravet Syndrome (DS)	Recruiting	3	160	Europe, Canada, US, RoW	LP352, Bexicaserin, Placebo, Placebo Comparator	Longboard Pharmaceuticals	Dravet Syndrome	09/26	10/26
NCT06719141: A Study to Investigate LP352 in Children and Adults with Developmental and Epileptic Encephalopathies (DEE)	Recruiting	3	320	Europe, Canada, US, RoW	LP352, Bexicaserin, Placebo, Placebo Comparator	Longboard Pharmaceuticals	Developmental and Epileptic Encephalopathy	10/26	11/26
NCT06908226: A Study to Investigate LP352 in Children and Adults With Developmental and Epileptic Encephalopathy (DEE)	Recruiting	3	324	US, RoW	LP352, Bexicaserin	Longboard Pharmaceuticals	Developmental and Epileptic Encephalopathy	11/27	12/27
NCT05626634: Open-label, Long-term Safety Study of LP352 in Subjects With Developmental and Epileptic Encephalopathy	Completed	2	41	US, RoW	LP352, bexicaserin	Longboard Pharmaceuticals	Developmental and Epileptic Encephalopathy, Dravet Syndrome, Lennox-Gastaut Syndrome	12/24	12/24
PACIFIC, NCT05364021: Study to Investigate LP352 in Subjects With Developmental and Epileptic Encephalopathies	Completed	1/2	52	US, RoW	LP352, Placebo, Placebo Comparator	Longboard Pharmaceuticals	Developmental and Epileptic Encephalopathy, Dravet Syndrome, Lennox Gastaut Syndrome	11/23	11/23
NCT06149663: Intermediate-Size Expanded Access Protocol (EAP) for LP352	Available	N/A		US, RoW	LP352	Longboard Pharmaceuticals	Dravet Syndrome, Lennox Gastaut Syndrome, Developmental and Epileptic Encephalopathies
LP143 / Lundbeck
No trials found
LP659 / Lundbeck
No trials found

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
bexicaserin (LP352) / Lundbeck
NCT06660394: A Phase 3, Placebo-Controlled Study to Investigate LP352 in Children and Adults with Dravet Syndrome (DS)	Recruiting	3	160	Europe, Canada, US, RoW	LP352, Bexicaserin, Placebo, Placebo Comparator	Longboard Pharmaceuticals	Dravet Syndrome	09/26	10/26
NCT06719141: A Study to Investigate LP352 in Children and Adults with Developmental and Epileptic Encephalopathies (DEE)	Recruiting	3	320	Europe, Canada, US, RoW	LP352, Bexicaserin, Placebo, Placebo Comparator	Longboard Pharmaceuticals	Developmental and Epileptic Encephalopathy	10/26	11/26
NCT06908226: A Study to Investigate LP352 in Children and Adults With Developmental and Epileptic Encephalopathy (DEE)	Recruiting	3	324	US, RoW	LP352, Bexicaserin	Longboard Pharmaceuticals	Developmental and Epileptic Encephalopathy	11/27	12/27
NCT05626634: Open-label, Long-term Safety Study of LP352 in Subjects With Developmental and Epileptic Encephalopathy	Completed	2	41	US, RoW	LP352, bexicaserin	Longboard Pharmaceuticals	Developmental and Epileptic Encephalopathy, Dravet Syndrome, Lennox-Gastaut Syndrome	12/24	12/24
PACIFIC, NCT05364021: Study to Investigate LP352 in Subjects With Developmental and Epileptic Encephalopathies	Completed	1/2	52	US, RoW	LP352, Placebo, Placebo Comparator	Longboard Pharmaceuticals	Developmental and Epileptic Encephalopathy, Dravet Syndrome, Lennox Gastaut Syndrome	11/23	11/23
NCT06149663: Intermediate-Size Expanded Access Protocol (EAP) for LP352	Available	N/A		US, RoW	LP352	Longboard Pharmaceuticals	Dravet Syndrome, Lennox Gastaut Syndrome, Developmental and Epileptic Encephalopathies
LP143 / Lundbeck
No trials found
LP659 / Lundbeck
No trials found